Finance

Lists
300119:SHE
Tianjin Ringpu Bio-Technology Co Ltd
CNÂ¥17.26
-3.25%
(-0.58) 1D
Sep 3, 3:04:52 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300119...
Open
CNÂ¥17.81
High
CNÂ¥18.05
Low
CNÂ¥17.25
Mkt. cap
8.29B
Avg. vol.
7.05M
Volume
4.85M
Dividend
2.32%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 13, 2026
P/E ratio
22.77
52-wk high
CNÂ¥22.96
52-wk low
CNÂ¥13.91
EPS
CNÂ¥0.76
Shares outstanding
464.75M
No. of employees
3K
Open
CNÂ¥17.81
High
CNÂ¥18.05
Low
CNÂ¥17.25
Mkt. cap
8.29B
Avg. vol.
7.05M
Volume
4.85M
Dividend
2.32%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 13, 2026
P/E ratio
22.77
52-wk high
CNÂ¥22.96
52-wk low
CNÂ¥13.91
EPS
CNÂ¥0.76
Shares outstanding
464.75M
No. of employees
3K
About Tianjin Ringpu Bio-Technology Co Ltd
CEO-
Employees2.8K
Founded1998
Headquarters-
SectorPharmaceutical industry
Websiteringpu.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
836.74M
854.13M
826.13M
894.33M
Cost of goods sold
486.26M
527.91M
497.91M
539.02M
Cost of revenue
486.26M
527.91M
497.91M
539.02M
Research and development expenses
53.61M
94.71M
45.33M
62.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
185.22M
184.65M
144.66M
163.41M
Operating expense
236.31M
304.33M
204.46M
220.55M
Total operating expenses
722.57M
832.24M
702.37M
759.58M
Operating income
114.16M
21.89M
123.75M
134.76M
Other non operating income
375.87K
-4.59M
-1.05M
-33.25M
EBT including unusual items
129.00M
30.18M
128.46M
112.52M
EBT excluding unusual items
133.91M
-15.83M
124.19M
106.69M
Income tax expense
10.27M
-13.50M
11.05M
8.02M
Effective tax rate
7.96%
-44.72%
8.61%
7.12%
Other operating expenses
-6.51M
18.54M
4.09M
5.50M
Net income
105.78M
38.21M
107.78M
96.33M
Net profit margin
12.64%
4.47%
13.05%
10.77%
Earnings per share
-
-
-
-
Interest and investment income
28.41M
-
9.65M
8.16M
Interest expense
-8.85M
-32.99M
-8.16M
-2.98M
Net interest expenses
19.56M
-32.99M
1.49M
5.18M
Depreciation and amortization charges
-
-
-
-
EBITDA
162.26M
74.51M
176.38M
187.04M
Gain or loss from assets sale
3.73M
-3.82M
-
-2.82K
AI content may include mistakes. Learn more
Google apps